These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 24526655)
1. Application of QbD principles for the evaluation of empty hard capsules as an input parameter in formulation development and manufacturing. Stegemann S; Connolly P; Matthews W; Barnett R; Aylott M; Schrooten K; Cadé D; Taylor A; Bresciani M AAPS PharmSciTech; 2014 Jun; 15(3):542-9. PubMed ID: 24526655 [TBL] [Abstract][Full Text] [Related]
2. Excipient variability and its impact on dosage form functionality. Dave VS; Saoji SD; Raut NA; Haware RV J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249 [TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Cole ET; Cadé D; Benameur H Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270 [TBL] [Abstract][Full Text] [Related]
4. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules. Gohil UC; Podczeck F; Turnbull N Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679 [TBL] [Abstract][Full Text] [Related]
5. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus. Garbacz G; Cadé D; Benameur H; Weitschies W Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609 [TBL] [Abstract][Full Text] [Related]
6. In-line ATR-UV and Raman Spectroscopy for Monitoring API Dissolution Process During Liquid-Filled Soft-Gelatin Capsule Manufacturing. Wan B; Zordan CA; Lu X; McGeorge G AAPS PharmSciTech; 2016 Oct; 17(5):1173-81. PubMed ID: 26604007 [TBL] [Abstract][Full Text] [Related]
7. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes. Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559 [TBL] [Abstract][Full Text] [Related]
8. Imprinting on empty hard gelatin capsule shells containing titanium dioxide by application of the UV laser printing technique. Hosokawa A; Kato Y; Terada K Drug Dev Ind Pharm; 2014 Aug; 40(8):1047-53. PubMed ID: 23786207 [TBL] [Abstract][Full Text] [Related]
9. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403. Wu Y; Zhao F; Paborji M Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962 [TBL] [Abstract][Full Text] [Related]
10. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules. Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518 [TBL] [Abstract][Full Text] [Related]
11. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets. Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical quality by design: product and process development, understanding, and control. Yu LX Pharm Res; 2008 Apr; 25(4):781-91. PubMed ID: 18185986 [TBL] [Abstract][Full Text] [Related]
13. Quality by design approach for formulation development: a case study of dispersible tablets. Charoo NA; Shamsher AA; Zidan AS; Rahman Z Int J Pharm; 2012 Feb; 423(2):167-78. PubMed ID: 22209997 [TBL] [Abstract][Full Text] [Related]
14. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules. Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644 [TBL] [Abstract][Full Text] [Related]
15. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study. Koehl NJ; Shah S; Tenekam ID; Khamiakova T; Sauwen N; Vingerhoets S; Coppenolle H; Holm R Pharm Res; 2021 Aug; 38(8):1439-1454. PubMed ID: 34378150 [TBL] [Abstract][Full Text] [Related]
16. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity. Ciper M; Bodmeier R Eur J Pharm Biopharm; 2006 Feb; 62(2):178-84. PubMed ID: 16260126 [TBL] [Abstract][Full Text] [Related]
17. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology. Bonhoeffer B; Kwade A; Juhnke M J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900 [TBL] [Abstract][Full Text] [Related]
18. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study. M K; Sistla R; Shastri NR Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823 [TBL] [Abstract][Full Text] [Related]
19. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films. Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737 [TBL] [Abstract][Full Text] [Related]
20. [A review on liquid-filled hard gelatin capsules]. Ma JH; Yang M; Zeng M; Chen XM; Lan J Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):602-5. PubMed ID: 18536390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]